Trinity Biotech (TRIB) Reports Q4 Loss of $0.23/sh

Trinity Biotech (NASDAQ: TRIB) reported Q4 EPS of ($0.23), versus $0.60 reported last year. Revenue for the quarter came in at $19.5 million versus the consensus estimate of $22 million.

For earnings history and earnings-related data on Trinity Biotech (TRIB) click here.

You May Also Be Interested In

• Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
• Alta Mesa Resources (AMR) Misses Q2 EPS by 128c
• Mammoth Energy Services (TUSK) Reports Q2 Loss of $0.01